ATAIBECKLEY’s Strategic Merger with Eli Lilly: Insider Sales, Capital Boost and Market‑Access Gains
ATAIBECKLEY merges with Eli Lilly, unlocking capital, global distribution, and milestone‑driven CVR payouts to accelerate psychedelic drug development.
4 minutes to read